Leflunomide Treatment Does Not Protect Neural Cells Following Oxygen-Glucose Deprivation (OGD) In Vitro (2024)
Journal Article
Curel, C. J. M., Nobeli, I., & Thornton, C. (2024). Leflunomide Treatment Does Not Protect Neural Cells Following Oxygen-Glucose Deprivation (OGD) In Vitro. Cells, 13(7), 631. https://doi.org/10.3390/cells13070631

Neonatal hypoxia-ischemia (HI) affects 2-3 per 1000 live births in developed countries and up to 26 per 1000 live births in developing countries. It is estimated that of the 750,000 infants experiencing a hypoxic-ischemic event during birth per year,... Read More about Leflunomide Treatment Does Not Protect Neural Cells Following Oxygen-Glucose Deprivation (OGD) In Vitro.

Pilot study to determine the effect of feeding a commercial feedstuff on gastric squamous gastric disease (ESGD) healing and prevention of recurrence. (2024)
Journal Article
Menzies-Gow, N. (in press). Pilot study to determine the effect of feeding a commercial feedstuff on gastric squamous gastric disease (ESGD) healing and prevention of recurrence. Journal of Equine Veterinary Science, https://doi.org/10.1016/j.jevs.2024.105015

Feedstuffs are often recommended to mitigate potential damage from acid associated with equine squamous gastric disease (ESGD). In acidic conditions, pectin alters its structure to one like mucus and binds the stomach mucosa, whilst alfalfa has a str... Read More about Pilot study to determine the effect of feeding a commercial feedstuff on gastric squamous gastric disease (ESGD) healing and prevention of recurrence..